DNA damage repair

January 30, 2020February 5, 2020

Clinical Trial of DNA Decoy to Make Ovarian Cancer’s Zejula More Effective Set to Open

News

A Phase 1b/2 clinical trial testing Onxeo’s AsiDNA as a potential treatment to overcome resistance to Zejula (niraparib) in ovarian cancer patients is set to begin, part of an agreement ... Read more

October 12, 2016October 31, 2016

Niraparib Maintenance Treatment Significantly Increased Outcomes for Ovarian Cancer Patients

News

Ovarian cancer patients with recurrent, platinum-sensitive disease may benefit greatly from niraparib maintenance treatment, according to data from a Phase 3 trial in which niraparib significantly prolonged patients’ progression-free survival compared ... Read more